REGN

E579608

REGN is the stock ticker symbol for Regeneron Pharmaceuticals, a major U.S.-based biotechnology company known for developing innovative antibody-based therapies.

All labels observed (2)

Label Occurrences
REGN canonical 3
NASDAQ:REGN 1

How this entity was disambiguated

Statements (45)

Predicate Object
instanceOf stock ticker symbol ⓘ
associatedWithIndustry biotechnology ⓘ
associatedWithSector healthcare ⓘ
country United States ⓘ
currency USD ⓘ
linked to: US dollar
exchangeMarket NASDAQ Global Select Market ⓘ
hasCUSIP 75886F107 ⓘ
hasISIN US75886F1075 ⓘ
hasUnderlyingCompanyBusinessModel research, development, manufacturing, and commercialization of biologic medicines ⓘ
hasUnderlyingCompanyCEO Leonard S. Schleifer ⓘ
hasUnderlyingCompanyCoFounder George D. Yancopoulos ⓘ
Leonard S. Schleifer ⓘ
hasUnderlyingCompanyCollaboration Sanofi ⓘ
hasUnderlyingCompanyCOVID19Involvement developed REGEN-COV for COVID-19 treatment ⓘ
hasUnderlyingCompanyEmployeeType research-intensive workforce ⓘ
hasUnderlyingCompanyExchangeListing NASDAQ:REGN ⓘ
linked to: REGN
hasUnderlyingCompanyFocus biopharmaceutical research and development ⓘ
hasUnderlyingCompanyFoundedYear 1988 ⓘ
hasUnderlyingCompanyHeadquarters Tarrytown, New York, United States ⓘ
linked to: Tarrytown, New York
hasUnderlyingCompanyIncorporationCountry United States ⓘ
hasUnderlyingCompanyLegalName Regeneron Pharmaceuticals, Inc. ⓘ
hasUnderlyingCompanyNotableProduct Dupixent (dupilumab) ⓘ
linked to: Dupixent

Eylea (aflibercept) ⓘ
linked to: Eylea

REGEN-COV (casirivimab and imdevimab) ⓘ
linked to: REGN-COV2
hasUnderlyingCompanyPrimaryBusiness development of antibody-based therapies ⓘ
hasUnderlyingCompanyRAndDFocus genetics-based drug discovery ⓘ
monoclonal antibodies ⓘ
hasUnderlyingCompanyResearchCollaboration Regeneron Genetics Center ⓘ
hasUnderlyingCompanyStateOfIncorporation New York ⓘ
hasUnderlyingCompanyStockCategory large-cap biotechnology stock ⓘ
hasUnderlyingCompanyTechnologyPlatform VelocImmune antibody technology ⓘ
hasUnderlyingCompanyTherapeuticArea cardiovascular diseases ⓘ
immunology ⓘ
oncology ⓘ
ophthalmology ⓘ
hasUnderlyingCompanyTicker REGN ⓘ
hasUnderlyingCompanyType public company ⓘ
hasUnderlyingCompanyWebsite https://www.regeneron.com ⓘ
isComponentOfIndex NASDAQ Biotechnology Index (NBI) ⓘ
S&P 500 Index ⓘ
listedOn NASDAQ ⓘ
regulatoryJurisdiction U.S. Securities and Exchange Commission ⓘ
represents Regeneron Pharmaceuticals, Inc. ⓘ
securityType common stock ⓘ
tradedAs REGN ⓘ

How these facts were elicited

Referenced by (4)

Full triples — surface form annotated when it differs from this entity's canonical label.

REGN → hasUnderlyingCompanyExchangeListing → NASDAQ:REGN ⓘ
linked to: REGN
REGN → tradedAs → REGN ⓘ